DK1330244T3 - Præparater der omfatter modafinilforbindelser - Google Patents
Præparater der omfatter modafinilforbindelserInfo
- Publication number
- DK1330244T3 DK1330244T3 DK01979747T DK01979747T DK1330244T3 DK 1330244 T3 DK1330244 T3 DK 1330244T3 DK 01979747 T DK01979747 T DK 01979747T DK 01979747 T DK01979747 T DK 01979747T DK 1330244 T3 DK1330244 T3 DK 1330244T3
- Authority
- DK
- Denmark
- Prior art keywords
- compositions
- modafinil compounds
- modafinil
- compounds
- particles
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical class C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960001165 modafinil Drugs 0.000 abstract 1
- -1 modafinil compound Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Psychology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23949000P | 2000-10-11 | 2000-10-11 | |
| US64082401A | 2001-10-10 | 2001-10-10 | |
| PCT/US2001/031904 WO2002030414A1 (en) | 2000-10-11 | 2001-10-11 | Compositions comprising modafinil compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1330244T3 true DK1330244T3 (da) | 2009-02-16 |
Family
ID=26932616
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01979747T DK1330244T3 (da) | 2000-10-11 | 2001-10-11 | Præparater der omfatter modafinilforbindelser |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1330244B1 (cs) |
| JP (1) | JP4593074B2 (cs) |
| AT (1) | ATE417608T1 (cs) |
| AU (1) | AU1167702A (cs) |
| BR (1) | BR0114814A (cs) |
| CY (1) | CY1110061T1 (cs) |
| CZ (1) | CZ306618B6 (cs) |
| DE (1) | DE60137069D1 (cs) |
| DK (1) | DK1330244T3 (cs) |
| ES (1) | ES2317943T3 (cs) |
| NZ (1) | NZ525236A (cs) |
| PT (1) | PT1330244E (cs) |
| WO (1) | WO2002030414A1 (cs) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7795246B2 (en) * | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
| US6919378B2 (en) | 2000-10-11 | 2005-07-19 | Cephalon, Inc. | Pharmaceutical solutions of modafinil compounds |
| US7229644B2 (en) * | 2002-05-23 | 2007-06-12 | Cephalon, Inc. | Pharmaceutical formulations of modafinil |
| US20040048931A1 (en) * | 2002-07-12 | 2004-03-11 | Craig Heacock | Modafinil pharmaceutical compositions |
| AU2003247001A1 (en) * | 2002-07-25 | 2004-02-16 | Ranbaxy Laboratories Limited | Processes for the preparation of oral dosage formulations of modafinil |
| US20040116532A1 (en) | 2002-09-13 | 2004-06-17 | Craig Heacock | Pharmaceutical formulations of modafinil |
| EP1603867A2 (en) | 2003-02-24 | 2005-12-14 | Mallinckrodt Inc. | Process for preparing benzhydrylthioacetamide |
| UA94380C2 (ru) * | 2003-09-18 | 2011-05-10 | Сефалон, Інк. | Фармацевтические композиции модафинила с модифицированным высвобождением |
| EP2292213A1 (en) * | 2004-02-06 | 2011-03-09 | Cephalon, Inc. | Compositions comprising a polymorphic form of armodafinil |
| AU2007272501A1 (en) * | 2006-07-12 | 2008-01-17 | Elan Pharma International Limited | Nanoparticulate formulations of modafinil |
| CA2803004A1 (en) * | 2010-06-29 | 2012-01-12 | Poniard Pharmaceuticals, Inc. | Oral formulations of kinase inhibitors |
| MX343894B (es) | 2010-06-30 | 2016-11-28 | Poniard Pharmaceuticals Inc * | Síntesis y uso de inhibidores de cinasa. |
| FR2987267B1 (fr) * | 2012-02-28 | 2015-01-16 | Debregeas Et Associes Pharma | Application du modafinil dans le traitement de substitution des cacainomanes |
| WO2018060843A1 (en) * | 2016-09-27 | 2018-04-05 | Novartis Ag | Surfactant systems for crystallization of organic compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04164024A (ja) * | 1990-10-29 | 1992-06-09 | Sankyo Co Ltd | 医薬物質含有自己乳化型脂肪乳剤組成物の製造方法 |
| FR2702968B1 (fr) * | 1993-03-23 | 1995-06-23 | Lafon Labor | Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation . |
| FR2706767B1 (cs) * | 1993-06-22 | 1995-09-08 | Lafon Labor | |
| US5447729A (en) * | 1994-04-07 | 1995-09-05 | Pharmavene, Inc. | Multilamellar drug delivery systems |
| US5618845A (en) * | 1994-10-06 | 1997-04-08 | Cephalon, Inc. | Acetamide derivative having defined particle size |
| FR2771004B1 (fr) * | 1997-11-19 | 2000-02-18 | Inst Curie | Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse |
| CA2331640A1 (en) * | 1998-05-07 | 1999-11-11 | Elan Corporation Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
| EP1146856B1 (en) * | 1999-01-12 | 2003-07-02 | Merck Sharp & Dohme Limited | Spheronised self-emulsifying system for hydrophobic and water-sensitive agents |
| ES2337838T3 (es) * | 2000-07-27 | 2010-04-29 | Teva Pharmaceutical Industries Ltd. | Modafinilo puro y cristalino y su procedimiento de preparacion. |
-
2001
- 2001-10-11 EP EP01979747A patent/EP1330244B1/en not_active Expired - Lifetime
- 2001-10-11 PT PT01979747T patent/PT1330244E/pt unknown
- 2001-10-11 JP JP2002533857A patent/JP4593074B2/ja not_active Expired - Lifetime
- 2001-10-11 BR BR0114814-1A patent/BR0114814A/pt active Search and Examination
- 2001-10-11 DE DE60137069T patent/DE60137069D1/de not_active Expired - Lifetime
- 2001-10-11 NZ NZ525236A patent/NZ525236A/xx not_active IP Right Cessation
- 2001-10-11 DK DK01979747T patent/DK1330244T3/da active
- 2001-10-11 AU AU1167702A patent/AU1167702A/xx active Pending
- 2001-10-11 WO PCT/US2001/031904 patent/WO2002030414A1/en active Search and Examination
- 2001-10-11 CZ CZ2003-1020A patent/CZ306618B6/cs not_active IP Right Cessation
- 2001-10-11 AT AT01979747T patent/ATE417608T1/de active
- 2001-10-11 ES ES01979747T patent/ES2317943T3/es not_active Expired - Lifetime
-
2009
- 2009-03-16 CY CY20091100287T patent/CY1110061T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT1330244E (pt) | 2009-01-27 |
| EP1330244B1 (en) | 2008-12-17 |
| BR0114814A (pt) | 2005-01-25 |
| CZ20031020A3 (en) | 2004-03-17 |
| ES2317943T3 (es) | 2009-05-01 |
| AU1167702A (en) | 2002-04-22 |
| DE60137069D1 (de) | 2009-01-29 |
| ATE417608T1 (de) | 2009-01-15 |
| JP2004517052A (ja) | 2004-06-10 |
| HK1054688A1 (en) | 2003-12-12 |
| CY1110061T1 (el) | 2015-01-14 |
| CZ306618B6 (cs) | 2017-04-05 |
| NZ525236A (en) | 2004-12-24 |
| WO2002030414A1 (en) | 2002-04-18 |
| EP1330244A1 (en) | 2003-07-30 |
| JP4593074B2 (ja) | 2010-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110061T1 (el) | Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης | |
| ATE340844T1 (de) | Stabile, wässerige zusammensetzungen zur behandlung von oberflächen , insbesondere geweben | |
| MXPA03005505A (es) | Compuesto modafinilo y mezclas de ciclodextrina. | |
| BRPI0508700A (pt) | uso de sns-595, composição farmacêutica, e, pó liofilizado | |
| ME01222B (me) | Nova kombinovana upotreba jedinjenja sulfonamida u liječenju kancera | |
| DE60106954D1 (de) | Resorcin-derivate | |
| EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
| ATE445389T1 (de) | Liposomale glucocorticoide | |
| DE60125945D1 (de) | Nasenspüler und dessen auslassstück | |
| AU9678501A (en) | Pharmaceutical solutions of modafinil compounds | |
| AU2003224747A1 (en) | Technetium-labeled rotenone derivatives, and methods of use thereof | |
| WO2003066597A3 (en) | Guanidino compounds | |
| BG66081B1 (bg) | Състави, съдържащи модафинилни съединения | |
| TR200402070T4 (tr) | Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı | |
| ATE391489T1 (de) | Haarbehandlungszusammensetzungen | |
| ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| EE200300057A (et) | Koostis vähi profülaktikaks ja raviks | |
| CY1105317T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| CY1105142T1 (el) | Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων | |
| PT1373249E (pt) | Derivados de imidazolidina, sua preparacao e sua utilizacao como agente anti-inflamatorio | |
| EA200400764A1 (ru) | 1,3-диарилпроп-2-ен-1-оны, композиция на их основе и применение | |
| EE200300466A (et) | Püridoindolooni derivaatide kasutamine ravimite valmistamiseks | |
| DE50310743D1 (de) | Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat | |
| DE60143020D1 (de) | 9-alkylamino-1-nitroacridin-derivate | |
| RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS |